| Budget Amount *help |
¥3,146,000 (Direct Cost: ¥2,420,000、Indirect Cost: ¥726,000)
Fiscal Year 2011: ¥1,508,000 (Direct Cost: ¥1,160,000、Indirect Cost: ¥348,000)
Fiscal Year 2010: ¥1,638,000 (Direct Cost: ¥1,260,000、Indirect Cost: ¥378,000)
|
|---|
| Research Abstract |
Human cells defend against retroviral infection through the actions of intrinsic restriction factors such as BST2.BST2 restricts the release of progeny virions from infected cells, while the HIV-1 protein Vpu antagonizes this restriction. Although the activity of Vpu is regulated by the phosphorylation, the precise regulatory mechanism for the phosphorylation-dependent Vpu function remains elusive. We here report that SCYL2 facilitates BST2-dependent restriction of viral release by inducing dephosphorylation of Vpu. The molecular machinery regulating the post-translational modifications of HIV proteins may be an alternative therapeutic target for HIV/AIDS.
|
